Lupin receives “A-” leadership rating from CDP in climate change and water security
This rating reflects Lupin's leadership in environmental transparency and performance
This rating reflects Lupin's leadership in environmental transparency and performance
No safety signals related to the vaccine candidate were identified
Offers affordable, high-quality solutions for diabetes care
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
These results represent critical milestones for Philogen, as Fibromun has the potential to become second product to successfully complete multinational clinical trials with registration potential
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
Subscribe To Our Newsletter & Stay Updated